Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 26, 2026 02:00 ET | Source: Tilray Brands, Inc.

Tilray Medical Brings Global Medical Cannabis Expertise to Cannabis Europa London 2026

LONDON, May 26, 2026 (GLOBE NEWSWIRE) -- Tilray Medical, a global leader in medical cannabis research, cultivation, production, products and distribution and a division of Tilray Brands, Inc....
May 26, 2026 01:15 ET | Source: Novartis Pharma AG

New Novartis data at ERA 2026 advance scientific understanding of kidney disease and reinforce portfolio strength

Late-breaking Phase III IgAN data for Vanrafia ALIGN and Fabhalta APPLAUSE-IgAN studies to be presented124-week Phase I/II zigakibart data evaluating treatment efficacy and safety in IgAN will be...
May 20, 2026 09:36 ET | Source: Research and Markets

In Silico Clinical Trials Strategic Business Research Report 2026-2032: Use in Rare Disease and Orphan Drug Development Expands Application Scope, Rising R&D Costs in Drug Development Spur Demand

Dublin, May 20, 2026 (GLOBE NEWSWIRE) -- The "In Silico Clinical Trials - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for In Silico...
May 19, 2026 08:00 ET | Source: Science 37, Inc.

Science 37 and Tufts CSDD Publish Landmark Study on Direct-to-Patient Clinical Trial Site Performance, Outperforming Industry Benchmarks

Tufts CSDD completes peer-reviewed analysis of Science 37’s Direct-to-Patient Clinical Trial Site, comparing performance to industry benchmarks.
May 19, 2026 07:30 ET | Source: Vertero Therapeutics, Inc.

Vertero Advances into Phase 1b Study with VT-5006 for the Treatment of Parkinson’s Disease

Vertero doses first Parkinson’s patient in Phase 1b study of VT-5006, a gut-selective therapy targeting disease progression.
May 19, 2026 06:30 ET | Source: Avance Clinical

Avance Clinical to Showcase Oncology Leadership at ASCO Annual Meeting 2026

Meet Avance Clinical's Oncology Center of Excellence expert team at ASCO Annual Meeting in Chicago, held 29 May – 2 June 2026.
May 18, 2026 08:30 ET | Source: Medidata Solutions, Inc.

Medidata’s Second Annual AI Report Shows a Shift from Pilots to Enterprise Adoption with 72.9% of Early Adopters Seeing a Reduction in Study Timelines

NEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today released its second annual report...
May 15, 2026 06:26 ET | Source: Research and Markets

Clinical Trial Agreements Course for CROs, Sponsors and Healthcare Organisations: Key Legal, Regulatory and IP Considerations for the EU and UK Markets (July 2, 2026)

Dublin, May 15, 2026 (GLOBE NEWSWIRE) -- The "Clinical Trial Agreements: Key Legal, Regulatory and IP Considerations for the EU and UK Markets (July 2, 2026)" training has been added to ...
May 11, 2026 11:24 ET | Source: Research and Markets

Gastric Cancer Global Clinical Trials Market Review Report 2026: Region, Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type

Dublin, May 11, 2026 (GLOBE NEWSWIRE) -- The "Gastric Cancer - Global Clinical Trials Review, 2026" has been added to ResearchAndMarkets.com's offering. This comprehensive report presents...
May 11, 2026 11:21 ET | Source: Research and Markets

Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Market Review Report 2026: Region, Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type

Dublin, May 11, 2026 (GLOBE NEWSWIRE) -- The "Chronic Lymphocytic Leukemia (CLL) - Global Clinical Trials Review, 2026" has been added to ResearchAndMarkets.com's offering. This comprehensive...